Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine
Author:
Affiliation:
1. Pfizer Inc, New York, NY, USA
2. Pfizer Inc, Collegeville, PA, USA
3. Pfizer Ltd, Walton Oaks, UK
Funder
Pfizer Inc
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmacology,Molecular Medicine,Immunology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14760584.2018.1409116
Reference91 articles.
1. Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era
2. U.S. Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination
3. Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: A review of economic evaluations (2006–2014)
4. Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
5. The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Serotype distribution and antimicrobial resistance of pediatric Streptococcus pneumoniae isolated from inpatients and outpatients at Beijing Children's Hospital;The Brazilian Journal of Infectious Diseases;2024-03
2. A cost-effectiveness analysis of pneumococcal conjugate vaccines in infants and herd protection in older adults in Colombia;Expert Review of Vaccines;2023-02-28
3. A Response to: Letter to the Editor Regarding ‘Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age’;Infectious Diseases and Therapy;2022-11-14
4. Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine compared to the 10-valent vaccine in children: predictive analysis in the Ecuadorian context;Journal of Pharmaceutical Health Services Research;2022-10-18
5. Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt;Human Vaccines & Immunotherapeutics;2022-09-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3